Yes, histology can help predict the response to treatment. For example, hormone receptor status in breast cancer (e.g., estrogen and progesterone receptors) can predict the response to hormonal therapies. Similarly, the presence of HER2/neu overexpression can indicate the likelihood of response to targeted therapies. Histological analysis can therefore guide personalized treatment plans.
